Related Experiment Video

Updated: Jun 5, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda

Jacqueline E Tate1, Annet Kisakye, Prosper Mugyenyi

  • 1Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, MS-A47, Atlanta, GA 30333, USA. jqt8@cdc.gov

Vaccine
|January 19, 2011
PubMed

Insights

Pneumococcal and rotavirus vaccines in Uganda could save thousands of lives and prevent numerous illnesses in children under five. Both vaccines are cost-effective, with pneumococcal vaccine being cost-saving.

Area of Science:

  • Public Health
  • Vaccinology
  • Health Economics

Background:

  • Pneumonia and rotavirus are leading causes of child mortality and morbidity in Uganda.
  • Vaccination programs are crucial for reducing the burden of vaccine-preventable diseases in children.
  • Assessing the economic impact of vaccination is vital for resource allocation in public health.

Purpose of the Study:

  • To evaluate the impact and cost-effectiveness of introducing pneumococcal and rotavirus vaccination programs in Uganda.
  • To estimate the number of lives saved and disease cases averted by these vaccines.
  • To determine the financial savings associated with vaccination from a public health system perspective.

Main Methods:

  • Disease-specific models were utilized to compare disease burden and costs with and without vaccination programs.
  • Impact was assessed by estimating lives saved and disease cases prevented in children under five.
  • Cost-effectiveness was analyzed from the perspective of the public health system in Uganda.

Main Results:

  • Pneumococcal vaccination could save 10,796 lives and prevent 94,071 Streptococcus pneumoniae cases annually.
  • Rotavirus vaccination could save 5,265 lives and prevent 94,729 rotavirus cases annually.
  • Pneumococcal vaccine is projected to be cost-saving, and rotavirus vaccine highly cost-effective at GAVI prices.

Conclusions:

  • Introducing pneumococcal and rotavirus vaccines in Uganda offers substantial public health benefits.
  • Both vaccination programs demonstrate excellent economic value, with significant cost savings and disease reduction.
  • These findings support the integration of pneumococcal and rotavirus vaccines into Uganda's national immunization schedule.

More Related Videos

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.